Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Japan's Nippon Zenyaku Kogyou (Zenoaq) has replicated its recent powerful financial performance in the first half of the firm's fiscal 2019.
Swedish firm Intervacc has finished the manufacturing stage of validation production batches for vaccine candidate Strangvac.
Evonik Industries has re-opened its two methionine manufacturing plants in Antwerp, Belgium, after a temporary outage of hydrocyanic acid (HCN) supply was resolved.
The US FDA has given a makeover to the National Antimicrobial Resistance Monitoring System (NARMS).
Zoetis' recent acquisitions are just part of the firm's strategy to become a significant third-party player in the US diagnostics reference laboratory sector.
Archer Daniels Midland Company has strengthened its foothold in Vietnam with a new livestock feed production facility.
Canadian firm Kane Biotech has recorded year-on-year growth of 127% in the third quarter of 2019.
Covetrus' shares are mirroring the company's recent improved performance after they reached their highest level since September this year.
Evonik Industries has closed its two methionine manufacturing plants in Antwerp, Belgium, following an issue regarding hydrocyanic acid (HCN) supply.
The Pirbright Institute has received $5.5 million in funding from the Bill & Melinda Gates Foundation to develop a livestock antibody hub.
US firm Zomedica Pharmaceuticals has seen its net loss for the year-to-date already surpass its annual loss during the whole of 2018.
Boehringer Ingelheim Animal Health has invested nearly $50 million in the extension of its manufacturing site in Barceloneta, Puerto Rico.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.